Nantahala Capital Management - Q4 2020 holdings

$3.23 Billion is the total value of Nantahala Capital Management's 126 reported holdings in Q4 2020. The portfolio turnover from Q3 2020 to Q4 2020 was 44.7% .

 Value Shares↓ Weighting
IWM SellISHARES TRput$597,983,000
-11.3%
3,050,000
-32.2%
18.53%
-10.1%
W  WAYFAIR INCcall$294,457,000
-22.4%
1,304,0000.0%9.12%
-21.4%
SGMS  SCIENTIFIC GAMES CORPcall$179,593,000
+18.8%
4,328,6000.0%5.56%
+20.4%
CDXS SellCODEXIS INC$109,164,000
+73.4%
5,000,620
-6.8%
3.38%
+75.6%
QADA BuyQAD INCcl a$78,100,000
+56.3%
1,236,146
+4.4%
2.42%
+58.3%
ESTA BuyESTABLISHMENT LABS HLDGS INC$76,865,000
+116.1%
2,042,099
+6.4%
2.38%
+118.9%
DLB SellDOLBY LABORATORIES INC$74,872,000
+20.3%
770,845
-17.9%
2.32%
+21.9%
VG BuyVONAGE HLDGS CORP$69,279,000
+30.6%
5,380,865
+3.8%
2.15%
+32.4%
QURE BuyUNIQURE NV$59,128,000
+1.4%
1,636,539
+3.4%
1.83%
+2.7%
CASH SellMETA FINL GROUP INC$56,326,000
+62.8%
1,540,646
-14.4%
1.74%
+64.9%
SBTX NewSILVERBACK THERAPEUTICS INC$54,384,0001,206,471
+100.0%
1.68%
VAC SellMARRIOTT VACTINS WORLDWID CO$52,828,000
+10.2%
384,987
-27.0%
1.64%
+11.7%
WYND SellWYNDHAM DESTINATIONS INC$50,126,000
+24.9%
1,117,394
-14.3%
1.55%
+26.6%
CVNA SellCARVANA COcall$48,794,000
-78.9%
203,700
-80.3%
1.51%
-78.6%
THC SellTENET HEALTHCARE CORPcall$47,721,000
-19.0%
1,195,100
-50.3%
1.48%
-17.9%
TA SellTRAVELCENTERS OF AMERICA INC$42,087,000
+65.8%
1,291,003
-0.6%
1.30%
+68.0%
GDEN SellGOLDEN ENTMT INC$40,400,000
+37.3%
2,031,172
-4.5%
1.25%
+39.1%
QURE BuyUNIQURE NVcall$40,196,000
+2.7%
1,112,500
+4.7%
1.24%
+4.0%
SNDX BuySYNDAX PHARMACEUTICALS INC$39,998,000
+102.4%
1,798,453
+34.3%
1.24%
+105.1%
LXFR BuyLUXFER HOLDINGS PLC$38,493,000
+34.7%
2,344,245
+2.9%
1.19%
+36.5%
KROS BuyKEROS THERAPEUTICS INC$37,705,000
+253.1%
534,514
+93.1%
1.17%
+257.2%
TBBK BuyBANCORP INC DEL$37,619,000
+65.9%
2,755,982
+5.0%
1.17%
+68.3%
DXPE BuyDXP ENTERPRISES INC$34,082,000
+40.8%
1,533,170
+2.2%
1.06%
+42.7%
IMXI SellINTERNATIONAL MNY EXPRESS IN$33,121,000
-0.6%
2,134,092
-8.0%
1.03%
+0.7%
BuyAPTOSE BIOSCIENCES INC$31,854,000
-22.9%
7,272,673
+5.6%
0.99%
-21.9%
CUE BuyCUE BIOPHARMA INC$31,360,000
-11.0%
2,506,772
+7.0%
0.97%
-9.8%
SFT NewSHIFT TECHNOLOGIES INCcl a$31,330,0003,788,396
+100.0%
0.97%
IMAX NewIMAX CORP$29,161,0001,618,281
+100.0%
0.90%
FBIO BuyFORTRESS BIOTECH INC$27,518,000
-17.2%
8,680,909
+5.5%
0.85%
-16.0%
IMTX SellIMMATICS N.V$27,131,000
+0.6%
2,514,489
-4.1%
0.84%
+1.9%
FCFS SellFIRSTCASH INC$27,119,000
+9.8%
387,189
-10.3%
0.84%
+11.3%
WVE BuyWAVE LIFE SCIENCES LTD$26,422,000
+30.8%
3,357,305
+41.2%
0.82%
+32.5%
INAQ NewINSU ACQUISITION CORP II$26,405,0001,698,075
+100.0%
0.82%
ALTG BuyALTA EQUIPMENT GROUP INC$25,688,000
+34.2%
2,600,012
+6.3%
0.80%
+35.8%
TFFP SellTFF PHARMACEUTICALS INC$25,253,000
-32.7%
1,763,476
-13.3%
0.78%
-31.9%
HCA  HCA HEALTHCARE INCput$24,669,000
+31.9%
150,0000.0%0.76%
+33.6%
CAR  AVIS BUDGET GROUPcall$24,532,000
+41.7%
657,7000.0%0.76%
+43.7%
UPLD BuyUPLAND SOFTWARE INC$22,995,000
+27.5%
501,100
+4.7%
0.71%
+29.0%
THC SellTENET HEALTHCARE CORP$22,547,000
+17.6%
564,659
-27.8%
0.70%
+19.3%
BDSI BuyBIODELIVERY SCIENCES INTL IN$21,519,000
+13.9%
5,123,671
+1.1%
0.67%
+15.4%
EHTH BuyEHEALTH INC$21,164,000
+37.4%
299,734
+53.7%
0.66%
+39.3%
EXAS  EXACT SCIENCES CORPput$19,874,000
+30.0%
150,0000.0%0.62%
+31.6%
AKBA BuyAKEBIA THERAPEUTICS INC$19,713,000
+36.7%
7,040,487
+22.5%
0.61%
+38.5%
EVRI SellEVERI HLDGS INC$18,834,000
+48.1%
1,363,786
-11.5%
0.58%
+50.1%
JYNT SellJOINT CORP$18,203,000
+23.3%
693,172
-18.3%
0.56%
+24.8%
BuyAKUMIN INC$17,412,000
-5.7%
5,784,556
+1.8%
0.54%
-4.4%
CERC BuyCERECOR INC$16,456,000
+24.9%
6,233,316
+7.6%
0.51%
+26.6%
CRHM BuyCRH MED CORP$16,119,000
+9.9%
6,892,005
+1.7%
0.50%
+11.1%
AGLE SellAEGLEA BIOTHERAPEUTICS INC$15,538,000
-29.8%
1,974,302
-36.8%
0.48%
-29.0%
VMD BuyVIEMED HEALTHCARE INC$15,232,000
+17.3%
1,951,480
+30.3%
0.47%
+18.9%
SLNO BuySOLENO THERAPEUTICS INC$15,192,000
-18.5%
7,871,356
+6.0%
0.47%
-17.4%
PAYA NewPAYA HOLDINGS INC$14,811,0001,100,000
+100.0%
0.46%
FTIVU SellFINTECH ACQUISITION CORP IVunit 12/31/2025$14,316,000
+4.5%
1,200,000
-38.5%
0.44%
+6.0%
SIC SellSELECT INTERIOR CONCEPTS INCcl a$13,599,000
-4.2%
1,901,943
-7.5%
0.42%
-3.0%
ZVO SellZOVIO INC$13,468,000
+18.0%
2,841,286
-0.4%
0.42%
+19.5%
CRIS NewCURIS INC$13,374,0001,632,915
+100.0%
0.41%
PAR SellPAR TECHNOLOGY CORP$12,703,000
-12.1%
202,312
-43.3%
0.39%
-10.9%
PLCE NewCHILDRENS PL INC$12,649,000252,472
+100.0%
0.39%
CBIO BuyCATALYST BIOSCIENCES INC$11,770,000
+50.2%
1,865,334
+2.4%
0.36%
+52.1%
CERE NewCEREVEL THERAPEUTICS HLDNG I$11,369,000685,704
+100.0%
0.35%
BuyFALCON MINERALS CORP$11,144,000
+38.1%
3,537,707
+6.9%
0.34%
+39.7%
FTOCU  FTAC OLYMPUS ACQUISITION CORunit 08/24/2025$10,870,000
+8.7%
1,000,0000.0%0.34%
+10.1%
DHX SellDHI GROUP INC$10,740,000
-1.8%
4,837,713
-0.0%
0.33%
-0.6%
FTCVU NewFINTECH ACQUISITION CORP Vunit 99/99/9999$10,670,0001,000,000
+100.0%
0.33%
IIIIU NewINSU ACQUISITION CORP IIIunit 12/31/2026$10,570,0001,000,000
+100.0%
0.33%
YTRA SellYATRA ONLINE INC$10,259,000
+157.1%
5,315,350
-0.1%
0.32%
+160.7%
ZGNX NewZOGENIX INC$10,232,000511,857
+100.0%
0.32%
LINC SellLINCOLN EDL SVCS CORP$10,108,000
-1.6%
1,555,022
-16.4%
0.31%
-0.3%
BMYRT SellBRISTOL-MYERS SQUIBB COright 99/99/9999$10,078,000
-71.0%
14,602,975
-5.4%
0.31%
-70.6%
RDI BuyREADING INTL INCcl a$9,959,000
+62.7%
1,983,928
+4.4%
0.31%
+65.2%
SGMS SellSCIENTIFIC GAMES CORP$9,844,000
-2.0%
237,260
-17.6%
0.30%
-0.7%
RMR NewRMR GROUP INCcl a$9,539,000246,994
+100.0%
0.30%
RFL SellRAFAEL HLDGS INC$9,080,000
+29.1%
389,370
-14.2%
0.28%
+30.7%
NATR BuyNATURES SUNSHINE PRODS INC$8,976,000
+29.9%
600,409
+0.5%
0.28%
+31.8%
 DARIOHEALTH CORP$8,491,000
-14.8%
594,2220.0%0.26%
-13.8%
HCA SellHCA HEALTHCARE INC$8,440,000
+31.6%
51,317
-0.3%
0.26%
+33.7%
PRCH NewPORCH GROUP INC$8,156,000600,000
+100.0%
0.25%
INAQW NewINSU ACQUISITION CORP II*w exp 09/01/202$8,082,000524,964
+100.0%
0.25%
APEN BuyAPOLLO ENDOSURGERY INC$7,783,000
+140.6%
2,289,263
+19.6%
0.24%
+143.4%
ARYA  ARYA SCIENCES ACQUISITION CO$7,595,000
+0.3%
700,0000.0%0.24%
+1.3%
SCPL SellSCIPLAY CORPORATIONcl a$7,065,000
-46.7%
510,122
-37.6%
0.22%
-45.9%
SSKN SellSTRATA SKIN SCIENCES INC$7,026,000
+11.1%
4,683,908
-0.0%
0.22%
+13.0%
CDXS NewCODEXIS INCcall$6,549,000300,000
+100.0%
0.20%
VG  VONAGE HLDGS CORPcall$6,438,000
+25.9%
500,0000.0%0.20%
+27.6%
XELA SellEXELA TECHNOLOGIES INC$6,299,000
+7.8%
15,168,086
-0.1%
0.20%
+8.9%
AFI BuyARMSTRONG FLOORING INC$6,217,000
+15.8%
1,627,441
+4.6%
0.19%
+17.7%
GLMD SellGALMED PHARMACEUTICALS LTD$5,993,000
-18.1%
1,926,899
-7.0%
0.19%
-17.0%
PAYAW NewPAYA HOLDINGS INC*w exp 10/16/202$5,252,000538,510
+100.0%
0.16%
MACK SellMERRIMACK PHARMACEUTICALS IN$5,180,000
+72.2%
751,843
-0.0%
0.16%
+75.0%
PRTY  PARTY CITY HOLDCO INC$5,088,000
+151.1%
834,0020.0%0.16%
+154.8%
ACET SellADICET BIO INC$4,833,000
-2.1%
344,011
-17.1%
0.15%
-0.7%
DVD SellDOVER MOTORSPORTS INC$4,302,000
+60.9%
1,895,337
-0.0%
0.13%
+62.2%
CEREW NewCEREVEL THERAPEUTICS HLDNG I*w exp 06/09/202$4,307,000283,332
+100.0%
0.13%
STRM  STREAMLINE HEALTH SOLUTIONS$4,296,0000.0%2,753,5990.0%0.13%
+1.5%
SRL SellSCULLY ROYALTY LTD$3,728,000
+0.7%
753,159
-0.1%
0.12%
+2.7%
CURIW NewCURIOSITYSTREAM INC*w exp 10/14/202$2,762,000200,000
+100.0%
0.09%
ACER SellACER THERAPEUTICS INC$2,593,000
-9.1%
989,755
-0.1%
0.08%
-8.0%
SIGA SellSIGA TECHNOLOGIES INC$2,334,000
-65.2%
321,031
-67.1%
0.07%
-64.9%
BCTG  BCTG ACQUISITION CORP$2,288,000
+10.4%
200,0000.0%0.07%
+12.7%
TSHA BuyTAYSHA GENE THERAPIES INC$2,085,000
+24.1%
78,576
+4.8%
0.06%
+27.5%
CYRN  CYREN LTD$1,894,000
-4.6%
1,839,2630.0%0.06%
-3.3%
HTGM NewHTG MOLECULAR DIAGNOSTICS IN$1,742,000363,622
+100.0%
0.05%
IMTXW NewIMMATICS N.V*w exp 01/01/202$1,499,000226,471
+100.0%
0.05%
SFTTW NewSHIFT TECHNOLOGIES INC*w exp 10/13/202$1,266,000249,999
+100.0%
0.04%
ALTGWS  ALTA EQUIPMENT GROUP INC*w exp 02/14/202$993,000
+208.4%
187,5000.0%0.03%
+210.0%
AMCX NewAMC NETWORKS INCcl a$921,00025,751
+100.0%
0.03%
CVNA NewCARVANA COcl a$921,0003,843
+100.0%
0.03%
NK BuyNANTKWEST INC$703,000
+100.3%
52,771
+4.3%
0.02%
+100.0%
MOTS SellMOTUS GI HLDGS INC$394,000
-3.4%
415,501
-0.5%
0.01%0.0%
 FALCON MINERALS CORP*w exp 07/21/202$375,000
+86.6%
878,0220.0%0.01%
+100.0%
KTRA NewKINTARA THERAPEUTICS INC$349,000272,969
+100.0%
0.01%
MDIA BuyMEDIACO HLDG INCcl a$270,000
+3.8%
103,680
+4.8%
0.01%0.0%
ATXI NewAVENUE THERAPEUTICS INC$180,00030,211
+100.0%
0.01%
FTAC ExitFINTECH ACQUISITION CORP III$0-22,978
-100.0%
-0.01%
NNBR ExitNN INC$0-132,821
-100.0%
-0.02%
INSUW ExitINSURANCE ACQUISITION CORP*w exp 03/31/202$0-249,999
-100.0%
-0.02%
ENVA ExitENOVA INTL INC$0-48,363
-100.0%
-0.02%
SNSS ExitSUNESIS PHARMACEUTICALS INC$0-691,651
-100.0%
-0.03%
ONDK ExitON DECK CAP INC$0-881,197
-100.0%
-0.04%
HTZGQ ExitHERTZ GLOBAL HLDGS INCcall$0-1,300,000
-100.0%
-0.04%
HTGM ExitHTG MOLECULAR DIAGNOSTICS IN$0-5,113,958
-100.0%
-0.05%
ONCT ExitONCTERNAL THERAPEUTICS INC$0-1,200,747
-100.0%
-0.06%
NEOS ExitNEOS THERAPEUTICS INC$0-4,610,000
-100.0%
-0.08%
GRAY ExitGRAYBUG VISION INC$0-250,000
-100.0%
-0.10%
DMAC ExitDIAMEDICA THERAPEUTICS INC$0-756,193
-100.0%
-0.10%
ITCI ExitINTRA CELLULAR THERAPIES INC$0-174,461
-100.0%
-0.14%
RCII ExitRENT A CTR INC NEW$0-177,165
-100.0%
-0.16%
AMRS ExitAMYRIS INC$0-2,531,191
-100.0%
-0.23%
ARYBU ExitARYA SCIENCES ACQUISTION COunit 06/09/2027$0-850,000
-100.0%
-0.29%
FTACU ExitFINTECH ACQUISITION CORP IIIunit 12/01/2023$0-977,022
-100.0%
-0.33%
IWM ExitISHARES TRrussell 2000 etf$0-86,413
-100.0%
-0.40%
HAL ExitHALLIBURTON COcall$0-1,086,200
-100.0%
-0.40%
INSU ExitINSURANCE ACQUISITION CORPcl a$0-1,225,538
-100.0%
-0.44%
FRG ExitFRANCHISE GROUP INC$0-598,334
-100.0%
-0.46%
INAQU ExitINSU ACQUISITION CORP IIunit 09/04/2025$0-1,575,000
-100.0%
-0.50%
PENN ExitPENN NATL GAMING INCput$0-300,000
-100.0%
-0.67%
WRLD ExitWORLD ACCEP CORP DEL$0-212,042
-100.0%
-0.68%
CAR ExitAVIS BUDGET GROUPput$0-1,500,000
-100.0%
-1.21%
IWM ExitISHARES TRcall$0-700,000
-100.0%
-3.21%
Original filings

The following EDGAR filing(s) were analyzed to create this report:

  • View 13F-HR filed 2021-02-16
Signatures

The EDGAR filing(s) were signed by:

About Nantahala Capital Management

Nantahala Capital Management is a hedge fund that was founded in 2004 by Wil Harkey. The firm is headquartered in Connecticut and has additional offices in New York and North Carolina. Nantahala Capital Management primarily invests in the technology, healthcare, and consumer sectors. The firm has a long-term investment approach and seeks to identify undervalued companies with strong growth potential.

Wil Harkey serves as the CEO and Chief Investment Officer of Nantahala Capital Management. He has over 20 years of experience in the finance industry and previously worked at Goldman Sachs and Maverick Capital. In addition to Harkey, the firm's leadership team includes COO and General Counsel, David Kozak, and CFO, Michael Kozak.

Nantahala Capital Management has a strong track record of generating positive returns for its investors. The firm's flagship fund, the Nantahala Fund, has delivered an annualized return of over 20% since its inception in 2006. The firm's success can be attributed to its disciplined investment approach and focus on long-term value creation.

Overall, Nantahala Capital Management is a well-respected hedge fund with a talented leadership team and a strong track record of performance. However, as with any investment, it is important for investors to conduct their own due diligence and carefully consider the risks before investing in the firm's funds.

It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.

Top long-term holdings
NameQuarters ownedLatest quarter ownedMax weighting
ISHARES TR42Q3 202327.2%
CODEXIS INC42Q3 20233.9%
PATHWARD FINANCIAL INC35Q3 20236.3%
SCIENTIFIC GAMES CORP34Q3 20225.3%
DOVER MOTORSPORTS INC34Q3 20210.5%
GOLDEN ENTMT INC33Q3 20232.1%
QAD INC32Q3 20212.6%
SCIENTIFIC GAMES CORP31Q4 20217.7%
DOLBY LABORATORIES INC31Q4 20205.6%
LINCOLN EDL SVCS CORP31Q4 20210.7%

View Nantahala Capital Management's complete holdings history.

Latest significant ownerships (13-D/G)
Nantahala Capital Management Q4 2020 significant holdings filed using form 13D/G when ownership exceeds 5% of a company's total stock issue.
FiledShares Percentage
AYTU BIOPHARMA, INCJune 16, 20231,086,81219.7%
Acer Therapeutics Inc.February 14, 20231,226,1917.5%
Aeglea BioTherapeutics, Inc.February 14, 20234,611,3027.5%
AKUMIN INC.February 14, 20232,206,9602.5%
ALTA EQUIPMENT GROUP INC.February 14, 20231,188,9853.7%
Apollo Endosurgery, Inc.February 14, 20234,056,6279.9%
Autolus Therapeutics plcFebruary 14, 20237,782,0184.7%
Bioventus Inc.February 14, 20233,168,5745.1%
CATALYST BIOSCIENCES, INC.February 14, 2023438,0551.4%
Drive Shack Inc.February 14, 20236,500,0007.0%

View Nantahala Capital Management's complete significant-ownership history.

Latest filings
TypeFiled
42024-03-21
42024-03-15
SC 13G2024-03-11
13F-HR/A2024-02-15
13F-HR2024-02-14
SC 13G/A2024-02-14
SC 13G/A2024-02-14
SC 13G/A2024-02-14
SC 13G/A2024-02-14
SC 13G/A2024-02-14

View Nantahala Capital Management's complete filings history.

Compare quarters

Export Nantahala Capital Management's holdings